Terms: = Skin cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
4 results:
1. Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.
Kansikas M; Vähätalo L; Kantelinen J; Kasela M; Putula J; Døhlen A; Paloviita P; Kärkkäinen E; Lahti N; Arnez P; Kilpinen S; Alcala-Repo B; Pylvänäinen K; Pöyhönen M; Peltomäki P; Järvinen HJ; Seppälä TT; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Nyström M
Cancer Res Commun; 2023 Mar; 3(3):361-370. PubMed ID: 36875157
[TBL] [Abstract] [Full Text] [Related]
2. Microsatellite Instability as a Biomarker for PD-1 Blockade.
Dudley JC; Lin MT; Le DT; Eshleman JR
Clin Cancer Res; 2016 Feb; 22(4):813-20. PubMed ID: 26880610
[TBL] [Abstract] [Full Text] [Related]
3. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
Ripperger T; Schlegelberger B
Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
[TBL] [Abstract] [Full Text] [Related]
4. High expression of the mismatch repair protein msh6 is associated with poor patient survival in melanoma.
Alvino E; Passarelli F; Cannavò E; Fortes C; Mastroeni S; Caporali S; Jiricny J; Cappellini GC; Scoppola A; Marchetti P; Modesti A; D'Atri S
Am J Clin Pathol; 2014 Jul; 142(1):121-32. PubMed ID: 24926095
[TBL] [Abstract] [Full Text] [Related]
